These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 9252719

  • 1. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI, Chow NH, Lai KH, Yang HB, Chan SH, Lin XZ, Cheng JS, Huang JS, Ger LP, Huang SM, Yen MY, Yang YF.
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
    Jin-no K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Endo H, Doi T, Mandai K, Ishitsuka H.
    Cancer; 1998 Apr 01; 82(7):1260-7. PubMed ID: 9529017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM, Tang ZY, Qin LX, Zhou J, Sun HC.
    J Exp Clin Cancer Res; 1999 Dec 15; 18(4):511-7. PubMed ID: 10746978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J, Hu J, Cai J.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):389-92. PubMed ID: 11810769
    [Abstract] [Full Text] [Related]

  • 18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G, Umeki K, Okano J, Kawasaki H.
    J Med; 1995 Oct 15; 26(5-6):295-308. PubMed ID: 8721905
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.